Geftibenz 250 Tablet

Gefitinib (250 mg)

Geftibenz 250 tablets are used to treat non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking the activity of specific enzymes that promote tumor growth.

This medication inhibits the epidermal growth factor receptor (EGFR) protein, an important target for many types of lung cancer cells. By suppressing EGFR activity, Geftibenz helps slow down tumor cell growth and potentially reduce their spread. This treatment is most effective for patients with tumors harboring specific genetic mutations in the EGFR gene.

Important Notes:
* Geftibenz must be prescribed and taken under the supervision of a qualified healthcare professional.
* Consult your doctor for proper dosage and follow-up instructions.
* While generally safe, potential side effects may occur. Seek immediate medical attention if experiencing any unusual symptoms.

Please remember that this description is intended for informational purposes only and should not be considered as medical advice. Always consult with a healthcare professional for accurate diagnosis and treatment.